iCAD Toekomstige groei
Future criteriumcontroles 0/6
De verwachting is dat iCAD de winst en omzet met respectievelijk 1.7% en 7.4% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 2.9% per jaar.
Belangrijke informatie
1.7%
Groei van de winst
2.9%
Groei van de winst per aandeel
Healthcare Services winstgroei | 30.8% |
Inkomstengroei | 7.4% |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | Low |
Laatst bijgewerkt | 21 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
iCAD, Inc. (NASDAQ:ICAD) Looks Just Right With A 47% Price Jump
Nov 09iCAD, Inc. (NASDAQ:ICAD) Stock Rockets 26% But Many Are Still Ignoring The Company
Aug 21iCAD, Inc.'s (NASDAQ:ICAD) P/S Still Appears To Be Reasonable
Jun 27iCAD, Inc. (NASDAQ:ICAD) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Feb 29We're Hopeful That iCAD (NASDAQ:ICAD) Will Use Its Cash Wisely
Sep 27We Think iCAD (NASDAQ:ICAD) Needs To Drive Business Growth Carefully
Jun 21Will iCAD (NASDAQ:ICAD) Spend Its Cash Wisely?
Feb 10Is iCAD (NASDAQ:ICAD) In A Good Position To Invest In Growth?
Nov 09Companies Like iCAD (NASDAQ:ICAD) Are In A Position To Invest In Growth
Jun 24iCAD (NASDAQ:ICAD) Is In A Good Position To Deliver On Growth Plans
Feb 23iCAD: Downside Seems Limited
Jan 16iCAD, Inc. (NASDAQ:ICAD) Analysts Just Cut Their EPS Forecasts Substantially
Jan 06Here's Why We're Not Too Worried About iCAD's (NASDAQ:ICAD) Cash Burn Situation
Nov 11Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 23 | -5 | N/A | N/A | 2 |
12/31/2025 | 19 | -7 | N/A | N/A | 3 |
12/31/2024 | 19 | -6 | N/A | N/A | 4 |
9/30/2024 | 19 | -5 | -5 | -4 | N/A |
6/30/2024 | 19 | -5 | -5 | -4 | N/A |
3/31/2024 | 18 | -5 | -6 | -5 | N/A |
12/31/2023 | 17 | -7 | -6 | -5 | N/A |
9/30/2023 | 17 | -9 | -7 | -7 | N/A |
6/30/2023 | 18 | -11 | -8 | -8 | N/A |
3/31/2023 | 17 | -9 | -10 | -10 | N/A |
12/31/2022 | 20 | -10 | -13 | -13 | N/A |
9/30/2022 | 23 | -12 | -12 | -11 | N/A |
6/30/2022 | 28 | -11 | -11 | -11 | N/A |
3/31/2022 | 33 | -13 | -11 | -10 | N/A |
12/31/2021 | 34 | -11 | -10 | -9 | N/A |
9/30/2021 | 36 | -9 | -9 | -9 | N/A |
6/30/2021 | 34 | -8 | -10 | -9 | N/A |
3/31/2021 | 32 | -7 | -10 | -9 | N/A |
12/31/2020 | 30 | -18 | -7 | -7 | N/A |
9/30/2020 | 29 | -19 | -9 | -8 | N/A |
6/30/2020 | 29 | -21 | -9 | -8 | N/A |
3/31/2020 | 31 | -22 | -7 | -7 | N/A |
12/31/2019 | 31 | -14 | -7 | -7 | N/A |
9/30/2019 | 29 | -14 | -7 | -6 | N/A |
6/30/2019 | 27 | -12 | -5 | -5 | N/A |
3/31/2019 | 26 | -9 | -5 | -5 | N/A |
12/31/2018 | 26 | -9 | -4 | -4 | N/A |
9/30/2018 | 27 | -10 | -4 | -4 | N/A |
6/30/2018 | 27 | -15 | N/A | -6 | N/A |
3/31/2018 | 28 | -17 | N/A | -6 | N/A |
12/31/2017 | 28 | -14 | N/A | -7 | N/A |
9/30/2017 | 27 | -13 | N/A | -7 | N/A |
6/30/2017 | 26 | -9 | N/A | -6 | N/A |
3/31/2017 | 27 | -8 | N/A | -5 | N/A |
12/31/2016 | 26 | -10 | N/A | -5 | N/A |
9/30/2016 | 27 | -9 | N/A | -6 | N/A |
6/30/2016 | 31 | -7 | N/A | -5 | N/A |
3/31/2016 | 34 | -33 | N/A | -4 | N/A |
12/31/2015 | 42 | -32 | N/A | -2 | N/A |
9/30/2015 | 48 | -30 | N/A | 3 | N/A |
6/30/2015 | 50 | -29 | N/A | 6 | N/A |
3/31/2015 | 49 | -3 | N/A | 5 | N/A |
12/31/2014 | 44 | -1 | N/A | 3 | N/A |
9/30/2014 | 39 | -5 | N/A | 2 | N/A |
6/30/2014 | 35 | -6 | N/A | -3 | N/A |
3/31/2014 | 33 | -7 | N/A | -2 | N/A |
12/31/2013 | 33 | -8 | N/A | -1 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachting is dat ICAD de komende 3 jaar verliesgevend zal blijven.
Winst versus markt: De verwachting is dat ICAD de komende 3 jaar verliesgevend zal blijven.
Hoge groeiwinsten: De verwachting is dat ICAD de komende 3 jaar verliesgevend zal blijven.
Omzet versus markt: De omzet van ICAD ( 7.4% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 9% per jaar).
Hoge groei-inkomsten: De omzet van ICAD ( 7.4% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van ICAD naar verwachting over 3 jaar hoog zal zijn